Publications by authors named "Janmejay Singh"

Claim this Profile
I
Iatrogenic Pancreatitis Post-Cholecystectomy-A Surgical Paradox: When Cholecystectomy Leads to Pancreatitis, a Case Report.
Fazeela Bibi, Janmejay Kumar Singh, Amina Asad, Qurat-Ul-Ain Akram, Aiman Sadiq

Clin Case Rep· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Effective Inhibitory Concentration of Interferon-β Correlates with Infectivity and Replication Fitness of SARS-CoV-2 Variants.
Janmejay Singh, Anbalagan Anantharaj, Parveen Kumar, Rajesh Pandey, Anil Kumar Pandey

J Interferon Cytokine Res· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrative analysis discovers Imidurea as dual multitargeted inhibitor of CD69, CD40, SHP2, lysozyme, GATA3, cCBL, and S-cysteinase from SARS-CoV-2 and M. tuberculosis.
Shaban Ahmad, Akash Pratap Singh, Nagmi Bano, Khalid Raza, Janmejay Singh

Int J Biol Macromol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity and safety of Biological E's CORBEVAX™ vaccine compared to COVISHIELD™ (ChAdOx1 nCoV-19) vaccine studied in a phase-3, single blind, multicentre, randomized clinical trial.
Subhash Thuluva, Vikram Paradkar, SubbaReddy Gunneri, Vijay Yerroju, Rammohan Mogulla, Janmejay Singh, Chandramani Singh

Hum Vaccin Immunother· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Omicron sub-lineage BA.5 infection results in attenuated pathology in hACE2 transgenic mice.
Zaigham Abbas Rizvi, Jyotsna Dandotiya, Srikanth Sadhu, Ritika Khatri, Janmejay Singh, Virendra Singh

Commun Biol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Ancestral SARS-CoV-2-Driven Antibody Repertoire Diversity in an Unvaccinated Individual Correlates with Expanded Neutralization Breadth.
Suprit Deshpande, Mohammed Yousuf Ansari, Jyoti Sutar, Payel Das, Nitin Hingankar, Savita Singh, Janmejay Singh

Microbiol Spectr· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BA.1, BA.2 and BA.2.75 variants show comparable replication kinetics, reduced impact on epithelial barrier and elicit cross-neutralizing antibodies.
Janmejay Singh, Anbalagan Anantharaj, Aleksha Panwar, Chitra Rani, Monika Bhardwaj

PLoS Pathog· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A broadly neutralizing monoclonal antibody overcomes the mutational landscape of emerging SARS-CoV-2 variants of concern.
Hilal Ahmad Parray, Naveen Narayanan, Sonal Garg, Zaigham Abbas Rizvi, Tripti Shrivastava, Janmejay Singh, Shivam Singh

PLoS Pathog· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, tolerability and immunogenicity of Biological E's CORBEVAX™ vaccine in children and adolescents: A prospective, randomised, double-blind, placebo controlled, phase-2/3 study.
Subhash Thuluva, Vikram Paradkar, SubbaReddy Gunneri, Vijay Yerroju, Rammohan Reddy Mogulla, Janmejay Singh

Vaccine· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of safety and immunogenicity of receptor-binding domain-based COVID-19 vaccine (Corbevax) to select the optimum formulation in open-label, multicentre, and randomised phase-1/2 and phase-2 clinical trials.
Subhash Thuluva, Vikram Paradkar, Subba Reddy Gunneri, Vijay Yerroju, Rammohan Mogulla, Janmejay Singh, Chandramani Singh

EBioMedicine· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pre-existing antibody levels negatively correlate with antibody titers after a single dose of BBV152 vaccination.
Suman Das, Janmejay Singh, Heena Shaman, Balwant Singh, Anbalagan Anantharaj

Nat Commun· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sub-optimal neutralisation of omicron (B.1.1.529) variant by antibodies induced by vaccine alone or SARS-CoV-2 Infection plus vaccine (hybrid immunity) post 6-months.
Guruprasad R Medigeshi, Gaurav Batra, Deepika Rathna Murugesan, Ramachandran Thiruvengadam, Souvick Chattopadhyay, Janmejay Singh, Savita Singh

EBioMedicine· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A combination of potently neutralizing monoclonal antibodies isolated from an Indian convalescent donor protects against the SARS-CoV-2 Delta variant.
Nitin Hingankar, Suprit Deshpande, Payel Das, Zaigham Abbas Rizvi, Constantinos Kurt Wibmer, Janmejay Singh, Savita Singh

PLoS Pathog· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis